A recent study in the MeLiM pig model showed that CD4−CD8+ T cells accounted for the majority of tumor-infiltrating lymphocytes (TILs) during late phases of melanoma regression and that only CD4+CD8hi TILs expanded during latest stages [28]. This evidence concerns the gene CD4 and melanoma.